Posted in | News | NanoOptics

API Technologies Shuts Down Its Nanotechnology R+D Subsidiary

API Technologies Corp. (OTC Bulletin Board: ATNY) ("API" or the "Company"), a prime contractor in sophisticated electronics, highly engineered systems, secure communications and electronic components and subsystems to the global defense and aerospace industries, today announced that it is closing its nanotechnology research and development subsidiary. 

Founded in 2000 and acquired by API in 2007, the NanoOpto subsidiary is located in Somerset, New Jersey.  The Company expects the shut down process to be completed within the next 90 days and will contribute in excess of $4 million to operating earnings.

"This decision, while difficult, will significantly improve API's operating results and allow us to deploy our capital and management resources on our expanding profitable defense business," said Stephen B. Pudles, Chief Executive Officer of API Technologies Corp.  "Together with our two recent successful acquisitions, API will now become a dedicated value-added subcontractor to the defense business and will be better able to serve the needs of our blue chip global customers."

The Company will report this segment as discontinued on its financial statements and all prior periods will be revised to reflect a consistent accounting treatment.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.